Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01

Salvatore Siena; Kanwal Raghav; Toshiki Masuishi; Kensei Yamaguchi; Tomohiro Nishina; Elena Elez; Javier Rodriguez; Ian Chau; Maria Di Bartolomeo; Hisato Kawakami; Fumitaka Suto; Makito Koga; Koichiro Inaki; Yusuke Kuwahara; Issey Takehara; Daniel Barrios; Kojiro Kobayashi; Axel Grothey; Takayuki Yoshino

doi:10.1038/s41467-025-56170-9

Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01

S Salvatore Siena K Kanwal Raghav T Toshiki Masuishi K Kensei Yamaguchi T Tomohiro Nishina (Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan) E Elena Elez (Vall d’Hebron Hospital Campus, Barcelona) J Javier Rodriguez I Ian Chau M Maria Di Bartolomeo H Hisato Kawakami F Fumitaka Suto M Makito Koga K Koichiro Inaki Y Yusuke Kuwahara I Issey Takehara D Daniel Barrios K Kojiro Kobayashi A Axel Grothey T Takayuki Yoshino (National Cancer Center Hospital East, Kashiwa, Japan)

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Nature Communications

Volume / Issue Vol. 16, Issue 1

Published January 15, 2025

DOI 10.1038/s41467-025-56170-9

ISSN 2041-1723

Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (19)

S

Salvatore Siena

K

Kanwal Raghav

T

Toshiki Masuishi

K

Kensei Yamaguchi

T

Tomohiro Nishina

Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan

E

Elena Elez

Vall d’Hebron Hospital Campus, Barcelona

J

Javier Rodriguez

I

Ian Chau

M

Maria Di Bartolomeo

H

Hisato Kawakami

F

Fumitaka Suto

M

Makito Koga

K

Koichiro Inaki

Y

Yusuke Kuwahara

I

Issey Takehara

D

Daniel Barrios

K

Kojiro Kobayashi

A

Axel Grothey

T

Takayuki Yoshino

National Cancer Center Hospital East, Kashiwa, Japan

Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01

Article Details

Journal Info

Authors (19)

Related Articles from this Journal

Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization

Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses

Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk

Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants

Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain